Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05765214 · ClinicalTrials.gov registry record · NA
Impact of Colorectal Cancer and Nutrition Education Program Among Minority Patients With Type 2 Diabetes
A NA study of Colorectal Cancer and Type 2 Diabetes, sponsored by Charles Drew University of Medicine and Science.
- Active
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT05765214 is a NA study of Colorectal Cancer and Type 2 Diabetes that is active but no longer recruiting, run by Charles Drew University of Medicine and Science. The registered enrollment target is 120 participants, below the 1,511-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05765214, a NA study of Colorectal Cancer and Type 2 Diabetes, is active but no longer recruiting, sponsored by Charles Drew University of Medicine and Science.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observation study is to deliver an education program designed to increase knowledge of colorectal cancer prevention and nutrition education in minorities with Type 2 diabetes. The main questions it aims to answer are: * What factors are associated with colorectal cancer screening among patients with type 2 diabetes? * Will implementing a customized patient-centered, culturally appropriate colorectal cancer education, and nutrition education program reduce the risk for colorectal cancer among patients with type 2 diabetes? * What is the impact of a patient-centered, culturally appropriate colorectal cancer education, and nutrition education intervention program on colorectal cancer screening and dietary indices among patients with type 2 diabetes compared to outcomes with patients who do not receive the intervention (usual care)? Participants randomized to the intervention group will: * receive a customized patient-centered, culturally appropriate education program * participate in eight (8) education sessions * be given booklet with colorectal cancer education and nutrition education to use as a workbook Researchers will compare colorectal cancer knowledge, perceptions, self-care, and social norms scores and dietary indices of the intervention group to the control group immediately and 6-months post intervention to see if the education program increased colorectal cancer knowledge and screenings and changes in dietary habits.
Conditions Studied
Interventions
- BEHAVIORAL Intervention Group (IG)
Study Locations (1)
California
- Charles R. Drew University - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05765214
The ClinicalTrials.gov registry entry for NCT05765214 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,511-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (92% lower). The listed sponsor is Charles Drew University of Medicine and Science, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Intervention Group (IG) is the first listed.
NCT05765214 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05765214 about?
NCT05765214 is a clinical study titled "Impact of Colorectal Cancer and Nutrition Education Program Among Minority Patients With Type 2 Diabetes". The goal of this observation study is to deliver an education program designed to increase knowledge of colorectal cancer prevention and nutrition education in minorities with Type 2 diabetes. The main questions it aims to answer are: * What factors are associated with colorectal cancer screening a...
What is the current status of trial NCT05765214?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2023-05-01. Estimated completion is 2026-06.
What conditions does trial NCT05765214 study?
This clinical trial studies the following conditions: Colorectal Cancer, Type 2 Diabetes.
What interventions are being tested in trial NCT05765214?
The interventions under investigation include: Intervention Group (IG) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05765214?
This trial is sponsored by Charles Drew University of Medicine and Science, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05765214 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
RECRUITING · NA
-
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
RECRUITING · NA
-
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.